



Argentina conducts a clinical study with 5-MeO-DMT to treat depression and anxiety, investigating the efficacy and safety of this psychedelic substance in volunteers
Technology inspired by fungi promises cultivated and sustainable chips
Energy Control detected in Spain ecstasy pills with MDMA doses exceeding 360 mg, more than double the limit considered high potency by the European Drug Agency
Research indicates that psilocybin can offer serenity to end-of-life patients, combining science, empathy, and a new perspective on dying
Research indicates that psilocybin can offer serenity to end-of-life patients, uniting science, empathy, and a new perspective on dying
The research, conducted by the Neuroscience Laboratory at UNILA, aims to advance the treatment of mental disorders through new scientific approaches
Research on psilocybin points to a new frontier in chronic pain treatment, combining science and empathy to offer lasting relief and better quality of life to millions of people
Indigenous peoples warn of the risk of exclusion in discussions about the legalization of psychedelics and call for respect for ancestral knowledge
Research reveals that psychedelic substances, such as psilocybin and LSD, may have anti-inflammatory action, opening up new therapeutic possibilities and reinforcing the connection between mind and body in modern medicine
Discover how memory, neuroplasticity, psychedelics, and medical cannabis can transform the treatment of depression and neurological diseases
Pennsylvania Democrats hold hearing on the use of psychedelics, such as psilocybin, in the treatment of resistant depression, bringing together experts and veterans to discuss science, regulation, and mental health
Article shows that psychedelics such as psilocybin and LSD can boost neuroplasticity, but emphasizes that subjective experience is essential for more precise mental health protocols